Clinical Trials Browser

Phase 2 × Vaccinia × 90 days × Clear all

NCT07006077 2026-02-27

Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms, Vaccinia